Clinical Trial Update: A Phase I Safety, PK and PD Study of KW-2478 in Patients With Multiple Myeloma, Chronic Lymphocytic Leukaemia or B-cell Non-Hodgkin's Lymphoma [Phase 1]

View source ↗

Summary

A Phase I safety, pharmacokinetic and pharmacodynamic study of KW-2478 in patients with multiple myeloma, chronic lymphocytic leukemia, or B-cell non-Hodgkin ly…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Non-hodgkin Lymphoma
• Chronic Lymphocytic Leukemia
• Multiple Myeloma

Drugs mentioned

• KW-2478

Snippet

Sponsor: Kyowa Kirin Co., Ltd. | Conditions: Multiple Myeloma, Chronic Lymphocytic Leukaemia | Phase 1 | Status: COMPLETED